AuraGxP Trusted
Team of Leaders

AuraGxP exists because Vikas Agarwal, PhD, spent 25+ years on the buying side of the tools it replaces — and never found one built the way the work actually runs. Across CDO and operating roles, he stood up QMS programs, governed the CRO and CDMO relationships that quality depends on, and owned the vendor and spend management controls wrapped around them. He saw the same structural gap every time: quality, vendor, and spend management run as separate systems that don't talk, so compliant operations become a tax on time and capital instead of a source of leverage.

‍
AuraGxP is the platform he couldn't buy. Quality, vendor, and spend management — integrated and engineered for the operational realities of modern life sciences biotechs and built to make compliant operations a competitive advantage rather than a cost of doing business.

‍

Arvind Govindarajan is a Technical Architect with extensive experience leading digital transformation and enterprise system implementations across Life Sciences R&D and Commercial functions. He specializes in solution architecture, system integrations, data migration, and change management for global organizations.

‍

A recognized industry speaker and contributor to Veeva Vault Safety, Arvind has authored whitepapers, presented at leading conferences, and helped organizations implement scalable, compliant technology solutions that accelerate innovation and operational excellence.

Diana I. Shea is a Quality Leader and consultant with over 20 years of experience in the pharmaceutical and biotechnology industries. She specializes in building and scaling phase-appropriate Quality Management Systems, GxP Quality programs, and inspection readiness initiatives for emerging and growth-stage organizations.

‍

Diana has led Quality Operations functions including Document Control, Training, and Quality Systems, while implementing compliant digital platforms that improve operational efficiency, inspection preparedness, and quality culture. Her expertise includes developing sustainable quality frameworks that support innovation while maintaining regulatory Quality across GxP environments.

‍

She holds a Master of Science in Management, complementing her strategic leadership and operational expertise. Diana is driven by a strong commitment to patient safety, continuous improvement, and advancing innovative therapies through practical, effective, and scalable quality practices.

Jaidyn Nguyen brings 17 years of experience getting drugs to market, with leadership roles at Genentech, AbbVie, and Allergan spanning clinical development strategy, operations, and procurement. She's built and run trials from protocol through submission, managed complex vendor ecosystems, and knows where the inefficiencies live.

‍

At AuraGxP, she applies that intricate framework knowledge and operational depth to help biopharma companies make smarter, faster decisions about how clinical work gets done.

Hem Vora is a seasoned corporate finance professional with nearly two decades of experience across biotech, life sciences, clinical research, telecommunications, and consulting. As the founder of Dharma Consulting Corp, he specializes in FP&A, commercial finance, ERP implementation, financial modeling, and strategic analytics. Hem has held leadership roles at companies including Alkermes, Cytel, and Parexel, where he managed multimillion-dollar revenues, forecasting, revenue recognition, and operational finance. His expertise lies in driving financial efficiency, business growth, and cross-functional strategic partnerships.

With over two decades of leadership across global CROs, pharmaceutical companies, and entrepreneurial ventures, Suraj brings deep expertise in clinical operations, regulatory quality, and digital transformation. A pharmacy graduate with a M. Pharm in pharmacy practice, he has led high-stakes global studies, secured USFDA- and EMA-backed marketing approvals, and co-founded a clinical research organization built on scalable systems and cross-functional governance.

At AuraGxP, Suraj leads end-to-end delivery of managed services and consulting programs. Drawing on proven expertise gained at Mylan, Parexel, and Quintiles, he is establishing rigorous operational frameworks and governance structures that embed quality into every delivery touchpoint. Suraj is recruiting, developing, and scaling a world-class delivery team positioned to set new standards for speed, consistency, and client success across AuraGxP's expanding global portfolio.

Krystal Kermott is Head of Business Development at AuraGxP, overseeing sales, marketing, and go-to-market strategy. She brings more than two decades of regulated life sciences experience to the role. Krystal began her career in Regulatory Affairs before moving into commercial roles, and that regulatory grounding continues to shape how she partners with both internal teams and customers today.

‍

She has held roles at Fortrea-owned Endpoint Clinical, Revvity Signals, Veeva Systems, IQVIA-owned Cenduit, Verisk 3E, Boehringer Ingelheim, and Parexel. Most recently at Endpoint Clinical, she led the US West and Strategic Partner sales teams while serving on the executive leadership team. Krystal specializes in clinical trial technology, strategic partnerships, and business growth, with deep expertise in SaaS solutions, clinical data, clinical operations, randomization and trial supply management, quality systems, and digital transformation for life sciences organizations.

‍

Krystal holds a B.S. in Biological Sciences from the University of California, Santa Barbara and a Women in Leadership Executive Education Certification from Cornell University's SC Johnson College of Business. She has also completed graduate coursework in Regulatory Affairs at San Diego State University and in Dispute Resolution at Pepperdine Law.

With nearly five decades of software engineering expertise, Neil has shaped the evolution of clinical research technology from its earliest days. Beginning his career at British Aerospace Dynamics Group, he transitioned into the life sciences sector over three decades ago—first as a consultant understanding clinical requirements at the ground level, then as a strategic architect building enterprise solutions. At eResearchTechnology, Neil spent 13 years as VP Technology Solutions, where he helped define the long-term vision for clinical operations software. When ERT's eClinical division merged with OmniComm Systems, he transitioned to Senior Director, leading business solutions for a major consolidator in the clinical software market. He continued this trajectory through Anju Software's acquisition of OmniComm, consistently translating complex clinical workflows into scalable, robust technology.

‍

Neil brings rare institutional knowledge of how the life sciences technology landscape evolved—the standards that emerged, the operational challenges that shaped solutions, and the strategic thinking required to serve demanding clinical clients. A physics and engineering graduate with an MSc in Information Technology, he combines deep technical credibility with pragmatic business insight.

‍

Joining AuraGxP, Neil brings this 30-year depth in clinical software and solutions architecture to help drive AuraGxP forward—grounded in hands-on experience of what actually works in regulated clinical environments.